Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis.

Euba G, Lora-Tamayo J, Murillo O, Pedrero S, Cabo J, Verdaguer R, Ariza J.

Antimicrob Agents Chemother. 2009 Oct;53(10):4305-10. doi: 10.1128/AAC.00444-09. Epub 2009 Aug 10.

2.

Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.

Pericas JM, Cervera C, del Rio A, Moreno A, Garcia de la Maria C, Almela M, Falces C, Ninot S, Castañeda X, Armero Y, Soy D, Gatell JM, Marco F, Mestres CA, Miro JM; Hospital Clinic Endocarditis Study Group..

Clin Microbiol Infect. 2014 Dec;20(12):O1075-83. doi: 10.1111/1469-0691.12756. Epub 2014 Aug 11.

3.

Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.

Miro JM, Cervera C, Garcia-de-la-Maria C, Del Rio A, Armero Y, Mestres CA, Grau JM, Marco F, Moreno A.

Scand J Infect Dis. 2008;40(11-12):968-72. doi: 10.1080/00365540802398945.

PMID:
18767002
4.

Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.

Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A.

Ann Intern Med. 2007 Apr 17;146(8):574-9.

PMID:
17438316
5.

Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.

Gavaldá J, Onrubia PL, Gómez MT, Gomis X, Ramírez JL, Len O, Rodríguez D, Crespo M, Ruíz I, Pahissa A.

J Antimicrob Chemother. 2003 Sep;52(3):514-7. Epub 2003 Aug 13.

PMID:
12917251
6.

Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.

Gavaldà J, Torres C, Tenorio C, López P, Zaragoza M, Capdevila JA, Almirante B, Ruiz F, Borrell N, Gomis X, Pigrau C, Baquero F, Pahissa A.

Antimicrob Agents Chemother. 1999 Mar;43(3):639-46.

7.

Combination therapy with ampicillin and daptomycin for treatment of Enterococcus faecalis endocarditis.

Sierra-Hoffman M, Iznaola O, Goodwin M, Mohr J.

Antimicrob Agents Chemother. 2012 Nov;56(11):6064. doi: 10.1128/AAC.01760-12. Epub 2012 Sep 10. No abstract available.

9.
10.

Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.

Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A.

Clin Infect Dis. 2013 May;56(9):1261-8. doi: 10.1093/cid/cit052. Epub 2013 Feb 7.

PMID:
23392394
11.

Enterococcal endocarditis revisited.

Pericás JM, Zboromyrska Y, Cervera C, Castañeda X, Almela M, Garcia-de-la-Maria C, Mestres C, Falces C, Quintana E, Ninot S, Llopis J, Marco F, Moreno A, Miró JM.

Future Microbiol. 2015;10(7):1215-40. doi: 10.2217/fmb.15.46. Epub 2015 Jun 29. Review.

PMID:
26118390
12.

Ampicillin plus ceftriaxone for high-level aminoglycoside-resistant Enterococcus faecalis endocarditis.

Singh A.

Ann Intern Med. 2008 Feb 5;148(3):243; author reply 243. No abstract available.

PMID:
18252687
13.

In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin.

Farina C, Russello G, Chinello P, Pasticci MB, Raglio A, Ravasio V, Rizzi M, Scarparo C, Vailati F, Suter F; Italian Infective Endocarditis Study Group (SEI)..

Chemotherapy. 2011;57(5):426-33. doi: 10.1159/000330458. Epub 2011 Nov 26.

PMID:
22122863
14.

[In vitro activity of ampicillin-ceftriaxone against Enterococcus faecalis isolates recovered from invasive infections].

Burguer Moreira N, Nastro M, Vay C, Famiglietti Á, Rodríguez CH.

Rev Argent Microbiol. 2016 Jan-Mar;48(1):57-61. doi: 10.1016/j.ram.2015.11.004. Epub 2016 Feb 6. Spanish.

15.

Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.

Hall Snyder A, Werth BJ, Barber KE, Sakoulas G, Rybak MJ.

J Antimicrob Chemother. 2014 Aug;69(8):2148-54. doi: 10.1093/jac/dku113. Epub 2014 Apr 28.

PMID:
24777900
16.

Summaries for patients. Successful treatment of aminoglycoside-resistant endocarditis with ampicillin and ceftriaxone.

[No authors listed]

Ann Intern Med. 2007 Apr 17;146(8):I56. No abstract available.

PMID:
17438313
17.

Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.

Kak V, Donabedian SM, Zervos MJ, Kariyama R, Kumon H, Chow JW.

Antimicrob Agents Chemother. 2000 Sep;44(9):2545-6.

18.
19.

Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.

Gavaldà J, Cardona PJ, Almirante B, Capdevila JA, Laguarda M, Pou L, Crespo E, Pigrau C, Pahissa A.

Antimicrob Agents Chemother. 1996 Jan;40(1):173-8.

Supplemental Content

Support Center